Table 2

Key resource (hospital length of stay) measured in the trial11

Item of resource useEarly high-flow groupStandard oxygen±rescue high-flow groupMean difference (95% CI)*x
Total HLoS in days(n=739)(n=733)
 Mean (SD)3.12 (2.43)2.94 (2.73)0.18 (−0.09 to 0.44)
 Median (IQR)2.50 (1.71–3.90)2.20 (1.48–3.55)
HLoS for those who failed treatment and received escalation of care (days)(n=87)(n=167)
 Mean (SD)5.82 (2.77)4.95 (4.13)0.87 (−0.09 to 1.85)
 Median (IQR)5.37 (3.71–7.31)4.0 (2.69–5.81)
HLoS for those who did not require escalation of care (days)(n=652)(n=566)
 Mean (SD)2.76 (2.14)2.35 (1.75)0.41 (0.18 to 0.63; p<0.001)
 Median (IQR)2.23 (1.60–3.37)1.88 (1.36–2.81)
HLoS for those who failed treatment and transferred to ICU (days)(n=87)(n=65)
 Mean (SD)5.82 (2.77)6.19 (5.30)−0.36 (−1.67 to 0.95)
 Median (IQR)5.37 (3.71–7.31)4.66 (3.06–6.88)
ICU length of stay (days)(n=87)(n=65)
 Mean (SD)2.63 (1.70)2.72 (2.31)−0.09 (−0.74 to 0.55)
 Median (IQR)2.22 (1.50–3.54)2.02 (1.34–2.98)
Duration of high-flow therapy (days)†(n=728)(n=162)
 Mean (SD)1.85 (1.70)2.26 (2.09)−0.41 (−0.71 to −0.11; p=0.008)
 Median (IQR)1.38 (0.74–2.40)1.62 (1.04–2.70)
  • *Student’s t-test of independent samples was used.

  • †Data on the duration of high-flow therapy were missing for 3 patients in the standard oxygen group and 11 in the high-flow group.

  • HLoS, total hospital length of stay—ie, in general ward and intensive care unit (ICU); IQR, interquartile range; SD, standard deviation.